Delivery Order SPE2DR25D9628-SPE2DR26FBTDT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,400.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count packages). This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency awarded a $12,364.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 5 mg on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge,...
- The Defense Logistics Agency awarded a $24,293.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The delivery order, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and was awarded on November 18, 2025. This award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 5 mg on June 17, 2025. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, is being fulfilled from Park Ridge, Illinois. The award utilizes no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 4, 2025, for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This award utilizes a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the...
- SPE2DR25D9628Indefinite Delivery Contract
- SPE2DR25D9628-SPE2DR26FBTDTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 20mg on November 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's position as a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The company will perform the work at its Park Ridge facility and deliver the product to support Department of Defense medical supply requirements. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA, the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 11/18/25 |